Complete immunotolerance induction after FEIBA prophylaxis in a haemophilia A patient with high-titre inhibitor
- 8 March 2012
- journal article
- letter
- Published by Wiley in Haemophilia
- Vol. 18 (3) , e75-e77
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low‐dose regimensPediatric Blood & Cancer, 2011
- Immune tolerance induction in haemophilia: evidence and the way forwardJournal of Thrombosis and Haemostasis, 2011
- Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitorsHaemophilia, 2010
- New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor developmentHaemophilia, 2010
- Home treatment with bypassing products in inhibitor patients: a 7.5-year experienceHaemophilia, 2009
- Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situationsHaemophilia, 2009
- Successful self‐infusion of activated prothrombin complex concentrate for prophylaxis in a child with a factor VIII inhibitorAmerican Journal of Hematology, 2006
- Measurement of anti-factor VIII IgG, IgG4 and IgM alloantibodies in previously untreated hemophilia A patients treated with recombinant factor VIII. Kogenate Japanese Clinical Study Group.1995